The Effect of Genotype on Methotrexate Polyglutamate Variability in Juvenile Idiopathic Arthritis and Association With Drug Response

被引:55
|
作者
Becker, Mara L. [1 ]
Gaedigk, Roger
van Haandel, Leon [2 ]
Thomas, Bradley
Lasky, Andrew
Hoeltzel, Mark
Dai, Hongying
Stobaugh, John [2 ]
Leeder, J. Steven
机构
[1] Childrens Mercy Hosp & Clin, Rheumatol Sect, Kansas City, MO 64108 USA
[2] Univ Kansas, Lawrence, KS 66045 USA
来源
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 01期
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; ACTIVE RHEUMATOID-ARTHRITIS; REDUCED FOLATE CARRIER; ORAL METHOTREXATE; PARENTERAL METHOTREXATE; COMMON POLYMORPHISMS; THYMIDYLATE SYNTHASE; DOSE METHOTREXATE; CONTROLLED-TRIAL; TOXICITY;
D O I
10.1002/art.30080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The response to and toxicity of methotrexate (MTX) are unpredictable in patients with juvenile idiopathic arthritis (JIA). Intracellular polyglutamation of MTX, assessed by measuring concentrations of MTX polyglutamates (MTXGlu), has been demonstrated to be a promising predictor of drug response. Therefore, this study was aimed at investigating the genetic predictors of MTXGlu variability and associations between MTXGlu and drug response in JIA. Methods. The study was designed as a single-center cross-sectional analysis of patients with JIA who were receiving stable doses of MTX at a tertiary care children's hospital. After informed consent was obtained from the 104 patients with JIA, blood was withdrawn during routine MTX-screening laboratory testing. Clinical data were collected by chart review. Genotyping for 34 single-nucleotide polymorphisms (SNPs) in 18 genes within the MTX metabolic pathway was performed. An ion-pair chromatographic procedure with mass spectrometric detection was used to measure MTXGlu(1-7). Results. Analysis and genotyping of MTXGlu was completed in the 104 patients. K-means clustering resulted in 3 distinct patterns of MTX polyglutamation. Cluster 1 had low red blood cell (RBC) MTXGlu concentrations, cluster 2 had moderately high RBC MTXGlu(1 + 2) concentrations, and cluster 3 had high concentrations of MTXGlu, specifically MTXGlu(3-5). SNPs in the purine and pyrimidine synthesis pathways, as well as the adenosine pathway, were significantly associated with cluster subtype. The cluster with high concentrations of MTXGlu(3-5) was associated with elevated liver enzyme levels on liver function tests (LFTs), and there were higher concentrations of MTXGlu(3-5) in children who reported gastrointestinal side effects and had abnormal findings on LFTs. No association was noted between MTXGlu and active arthritis. Conclusion. MTXGlu remains a potentially useful tool for determining outcomes in patients with JIA being treated with MTX. The genetic predictors of MTXGlu variability may also contribute to a better understanding of the intracellular biotransformation of MTX in these patients.
引用
收藏
页码:276 / 285
页数:10
相关论文
共 50 条
  • [1] Analysis of Intracellular Methotrexate Polyglutamates in Patients With Juvenile Idiopathic Arthritis Effect of Route of Administration on Variability in Intracellular Methotrexate Polyglutamate Concentrations
    Becker, Mara L.
    van Haandel, Leon
    Gaedigk, Roger
    Lasky, Andrew
    Hoeltzel, Mark
    Stobaugh, John
    Leeder, J. Steven
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (06): : 1803 - 1812
  • [2] THE RELATIONSHIP OF FOLATE AND METHOTREXATE WITH DRUG RESPONSE IN JUVENILE IDIOPATHIC ARTHRITIS
    Patel, D.
    vanHaandel, L.
    Lasky, A.
    Hoeltzel, M. F.
    Leeder, J. S.
    Becker, M. L.
    [J]. PEDIATRIC RESEARCH, 2011, 70 (04) : 431 - 431
  • [3] CLINICAL AND GENETIC PREDICTORS OF METHOTREXATE POLYGLUTAMATE PATTERNS IN JUVENILE IDIOPATHIC ARTHRITIS.
    Becker, M. L.
    Gaedigk, R.
    van Haandel, L.
    Thomas, B.
    Stobaugh, J.
    Leeder, J. S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S68 - S68
  • [4] CLINICAL AND GENETIC PREDICTORS OF METHOTREXATE POLYGLUTAMATE PATTERNS IN JUVENILE IDIOPATHIC ARTHRITIS.
    Becker, M. L.
    Gaedigk, R.
    van Haandel, L.
    Thomas, B.
    Stobaugh, J.
    Leeder, J. S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S2 - S2
  • [5] Association of Plasma Metabolomic Profiles with Methotrexate Response in Juvenile Idiopathic Arthritis
    Funk, Ryan
    Becker, Mara
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72 : 34 - 36
  • [6] Predictors of response to methotrexate in juvenile idiopathic arthritis
    Mohamed Albarouni
    Ingrid Becker
    Gerd Horneff
    [J]. Pediatric Rheumatology, 12
  • [7] Predictors of response to methotrexate in juvenile idiopathic arthritis
    Albarouni, Mohamed
    Becker, Ingrid
    Horneff, Gerd
    [J]. PEDIATRIC RHEUMATOLOGY, 2014, 12
  • [8] Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis
    Dolezalová, P
    Krijt, J
    Chládek, J
    Nemcová, D
    Hoza, J
    [J]. RHEUMATOLOGY, 2005, 44 (01) : 74 - 79
  • [9] Genetic determinants for methotrexate response in juvenile idiopathic arthritis
    Pastore, Serena
    Stocco, Gabriele
    Favretto, Diego
    De Ludicibus, Sara
    Taddio, Andrea
    d'Adamo, Pio
    Malusa, Noelia
    Addobbati, Riccardo
    Decorti, Giuliana
    Lepore, Loredana
    Ventura, Alessandro
    [J]. FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [10] GENOME-WIDE ASSOCIATION STUDY OF METHOTREXATE NON-RESPONSE IN JUVENILE IDIOPATHIC ARTHRITIS
    Sampath, Sunil
    Viatte, Sebastien
    Smith, Samantha L.
    Cobb, Joanna
    Hinks, Anne
    Hyrich, Kimme L.
    Sergeant, Jamie C.
    Wedderburn, Lucy R.
    Beresford, Michael W.
    Thomson, Wendy
    [J]. RHEUMATOLOGY, 2017, 56 : 14 - 15